Publications by authors named "Mooza Al Ali"

Article Synopsis
  • The study investigates the effectiveness of two antibiotics, ceftazidime-avibactam (CZA) and ceftolozane-tazobactam (C/T), in treating multidrug-resistant Pseudomonas aeruginosa infections in patients on renal replacement therapy.
  • A total of 45 patients were analyzed, with similar clinical cure rates for both CZA (48%) and C/T (60%), and no significant differences in outcomes such as microbiologic cure, recurrence, or 30-day mortality.
  • The results suggest that both antibiotics are equally effective for clinical cure in the studied population, but further research with larger sample sizes is necessary to validate these findings.
View Article and Find Full Text PDF

Unlabelled: Ceftolozane-tazobactam (C/T) recommended dosing in patients undergoing renal replacement therapies (RRT) is lacking evidence. The objective of this study was to evaluate the clinical outcomes of C/T dosing in patients on RRT.

Materials And Methods: A retrospective descriptive study conducted at our institution between May 1, 2017, and March 15, 2022.

View Article and Find Full Text PDF

Introduction: The suggested dose of ceftazidime-avibactam (CEF/AVI) in patient with multidrug resistant organisms and utilizing renal replacement therapies (RRTs) is not validated in clinical studies. The objective of this study was to evaluate the microbiologic cure of bacteremia and pneumonia using the recommended CEF/AVI dosing in patients utilizing RRT.

Methods: A retrospective observational study conducted at our institution between September 15, 2018 and March 15, 2022.

View Article and Find Full Text PDF